Experienced venture investor and operator focused on early-stage technology and healthcare companies. Laura Robayo brings product and go-to-market experience, helping founders scale revenue and corporate partnerships. Background combines operating roles and investor diligence, with emphasis on capital-efficient growth, founder-led businesses and cross-border expansion. Active in board-level advising and deal sourcing across seed to Series A.
Experienced venture investor and operator focused on early-stage technology and healthcare companies. Laura Robayo brings product and go-to-market experience, helping founders scale revenue and corporate partnerships. Background combines operating roles and investor diligence, with emphasis on capital-efficient growth, founder-led businesses and cross-border expansion. Active in board-level advising and deal sourcing across seed to Series A.
Focuses on capital-efficient, founder-led seed to Series A investments in technology and healthcare where product-market fit and early revenue mechanics are clear. Emphasizes hands-on go-to-market and partnership enablement, board-level operational support, and cross-border scaling. Pursues thesis-driven deals with measurable unit economics, prefers concentrated portfolios, and balances patient, growth-oriented time horizons with disciplined downside protection through staged capital and tight milestone underwriting.
Focuses on capital-efficient, founder-led seed to Series A investments in technology and healthcare where product-market fit and early revenue mechanics are clear. Emphasizes hands-on go-to-market and partnership enablement, board-level operational support, and cross-border scaling. Pursues thesis-driven deals with measurable unit economics, prefers concentrated portfolios, and balances patient, growth-oriented time horizons with disciplined downside protection through staged capital and tight milestone underwriting.
| Trades 167 | Longs Won 125/167 74% | Profit Factor 51.04 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $662,455.1 |
| Average Win $224,209.06 | Best Trade (Jul 14) $6.11M | Sharpe Ratio -103.38 |
| Average Loss -$13,073.47 | Worst Trade (Jul 14) -$162,319.88 | Z-Score 5.71 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w 6d | Expectancy $164,533.21 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 12,821 | 11,538 | 10,256 | 8,974 | 7,692 | 6,410 | 5,128 | 3,846 | 2,564 | 1,282 |